在NR3C1基因的新型变异的表征:区分葡萄糖皮质激素耐药性和库辛综合征
Margaux Laulhé1, Michal Yacobi Bach2,3, Julie Perrot1
1Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, 94276 Le Kremlin-Bicêtre, France.
The Journal of clinical endocrinology and metabolism
|November 28, 2024
概括
一种新的葡萄糖皮质体受体基因变异会导致泛性葡萄糖皮质体耐药综合征. 这一发现有助于早期诊断,并防止这种罕见的内分泌疾病不必要的治疗.
科学领域:
- 内分泌学 在内分泌学.
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 初级通用葡萄糖皮质体抗性综合征 (GGRS) 是一种罕见的内分泌疾病.
- 它是由NR3C1基因中的功能丧失变异引起的,NR3C1基因对葡萄糖皮质体受体进行编码.
- 在NR3C1的DNA结合域中发现了一种新型异合体误解变异 (p.Phe444Val).
研究的目的:
- 描述一种与初级GGRS相关的新型NR3C1基因变异.
- 为了描述这种变体的功能影响.
- 强调识别GGRS临床特征的重要性,以便及时诊断.
主要方法:
- 一个59岁的男性患有尿液自由皮质醇和高血压的病例研究.
- 在HEK 293T细胞中进行功能性ex vivo测定 (过渡性转染),以评估变异的转录活性和核转位.
- 对甲抑制试验,ACTH和唾液皮质醇水平的分析.
主要成果:
- 新型的p.Phe444Val变体与野生型相比,表现出显著缺乏转录活性.
- 观察到对德克萨米他的反应中,该变体受体的有效核转位.
- 这些发现表明,DNA结合缺陷是该患者GGRS的机制.
结论:
- 据报道,一种新的异构性NR3C1基因突变 (p.Phe444Val) 导致了原发性GGRS.
- 这一案例强调了需要提高对GGRS临床和实验室表现的认识.
- 早期诊断至关重要,以避免误诊和潜在的有害干预.
相关概念视频
Adrenal Gland Disorders
1.3K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.3K
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K


